HypeCheck

Updated · AI-assisted evidence analysis

Welactin Canine Omega-3 Supplement Review 2026: What Does the Evidence Show?

Dog studies exist for omega-3s, but none tested Welactin and many claims lack data — Too early to call

See full analysis ↓ Methodology →
Share: Post Share

Claims vs Evidence

4 claims assessed. Support depends on the study results, formulation, and population. Matching an ingredient or dose alone does not establish a benefit.

"Supports skin and coat health, plus overall wellness" Partial

Marine-oil trials in dogs with itchy or atopic skin point toward less itch and better coat, but samples were 16 to 29 dogs, products and amounts varied, and one trial's skin lesion scores did not change. Healthy-dog coat data and 'overall wellness' outcomes were not found in the reviewed sources. No exact-product trial was found.

Source: Double-blinded Crossover Study with Marine Oil Supplementation Containing High-dose icosapentaenoic Acid for the Treatment of Canine Pruritic Skin Disease. →

Marine oil crossover trial in canine pruritic skin disease

Double-blinded randomized crossover trial versus corn oil · ingredient

Marine oil improved pruritus, alopecia and coat character versus corn oil (P<0.02, P<0.05, P<0.001).

Limitations: Small sample; dogs with itchy skin disease, not healthy dogs; abstract only; 1994 publication.

Species
dog
Participants / condition
16 dogs that completed the study, with idiopathic pruritus, confirmed atopy and/or flea allergy
Formulation
Marine oil capsule (MVP product), 180 mg EPA + 120 mg DHA per 1 mL capsule; not Welactin
Studied amount, not dosing advice
One capsule per 4.55 kg body weight daily, about 66 mg/kg EPA+DHA (calculated from reported figures)
Duration
6 weeks per period with a 3-week washout
Funding / conflicts
Not reported in abstract; sponsor and conflicts unavailable.
Study source ↓
Fish oil and oclacitinib dose in atopic dogs

Placebo-controlled, double-blind trial · ingredient

Oclacitinib dose fell in the fish-oil group, itch scale was lower than placebo at day 112, and quality of coat improved only in the PUFA group. CADESI-04 skin lesion score did not change over time or differ between groups.

Limitations: Small sample; dogs were on a prescription drug; lesion score showed no change; abstract only.

Species
dog
Participants / condition
22 client-owned dogs with atopic dermatitis receiving oclacitinib
Formulation
A fish oil product (PUFA) versus paraffin oil placebo; brand not named in abstract
Studied amount, not dosing advice
EPA+DHA amount not reported in abstract
Duration
16 weeks
Funding / conflicts
Not reported in abstract; sponsor and conflicts unavailable.
Study source ↓
Omega-3 fatty acids in canine atopic dermatitis

Double-blinded, placebo-controlled randomized trial · ingredient

Clinical scores improved with flax oil and the commercial preparation but not placebo. No link between fatty acid intake or omega-6:3 ratio and clinical scores.

Limitations: Small sample; atopic dogs only; abstract only; flax arm is not marine oil.

Species
dog
Participants / condition
29 dogs with atopic dermatitis
Formulation
Flax oil, or a commercial EPA/DHA preparation, versus mineral oil placebo; brand not named in abstract
Studied amount, not dosing advice
EPA 50 mg/kg/day + DHA 35 mg/kg/day (commercial preparation arm); flax oil 200 mg/kg/day
Duration
10 weeks
Funding / conflicts
Not reported in abstract; publication type lists non-U.S. government research support; sponsor details unavailable.
Study source ↓
"Omega-3s support joint health" Partial

Randomized dog trials in osteoarthritis point the same way, but they are ingredient-level or food-based evidence. No exact-product trial of Welactin was found in this search. Most trials used fish-oil foods with daily EPA+DHA not stated, and the label's per-kg amount spans below and above the one oil trial's 69 mg/kg/day depending on dog weight. In a 2024 trial where omega-3 plus vitamin E was the comparator, only the collagen group improved significantly. Follow-up in the reviewed trials ran from 12 weeks to about 6 months.

Source: A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. →

EPA+DHA oil versus placebo in dogs with osteoarthritis

Prospective, randomized, double-blind, placebo-controlled trial · ingredient

Discomfort, lameness and joint severity scores and blood fatty acid measures improved versus placebo (p<0.05). No major side effects observed.

Limitations: Single product; effect sizes not in abstract; abstract only.

Species
dog
Participants / condition
78 client-owned dogs with osteoarthritis of hip and/or stifle; 74 completed
Formulation
Triglyceride n-3 oil versus placebo oil; brand not named in abstract
Studied amount, not dosing advice
Average 69 mg EPA+DHA/kg/day
Duration
84 days
Funding / conflicts
Not reported in abstract; publication type lists non-U.S. government research support; conflicts unavailable.
Study source ↓
Fish oil food and weight bearing in dogs with osteoarthritis

Randomized, double-blinded, controlled trial · different formulation

Peak vertical force rose 5.6% in the test group versus 0.4% in controls; 82% of test dogs improved versus 38% of controls.

Limitations: Small sample; food trial, not a supplement; abstract only.

Species
dog
Participants / condition
38 client-owned dogs with osteoarthritis (16 control, 22 test) at 2 university clinics
Formulation
Test food containing 3.5% fish oil omega-3 fatty acids versus typical commercial food; not a liquid supplement
Studied amount, not dosing advice
3.5% fish oil omega-3 fatty acids in food; daily EPA+DHA not stated
Duration
90 days
Funding / conflicts
Not reported in abstract; publication type lists non-U.S. government research support; sponsor and conflicts unavailable.
Study source ↓
Multicenter assessment of omega-3 food in canine osteoarthritis

Randomized, double-blinded, controlled multicenter trial · different formulation

Higher serum omega-3; owners reported better ability to rise and play at 6 weeks and to walk at 12 and 24 weeks versus control.

Limitations: Owner-reported outcomes; food trial; abstract only.

Species
dog
Participants / condition
127 client-owned dogs with osteoarthritis from 18 veterinary clinics
Formulation
Test food with 31-fold more total omega-3 and lower omega-6:omega-3 ratio versus typical commercial food
Studied amount, not dosing advice
Food-based; daily EPA+DHA not stated
Duration
Fed 6 months; assessments at 6, 12 and 24 weeks
Funding / conflicts
Not reported in abstract; publication type lists non-U.S. government research support; sponsor and conflicts unavailable.
Study source ↓
Fish oil food and carprofen dosage

Randomized, controlled, multisite clinical trial · different formulation

Carprofen dose decreased significantly faster in dogs on the supplemented diet.

Limitations: Outcome is drug dose, not a direct joint measure; dogs were on carprofen; abstract only.

Species
dog
Participants / condition
131 client-owned dogs with stable chronic osteoarthritis at 33 US hospitals
Formulation
Fish-oil supplemented food versus low-omega-3 control food, with carprofen
Studied amount, not dosing advice
Food-based; EPA+DHA amount not stated in abstract
Duration
12 weeks
Funding / conflicts
Not reported in abstract; publication type lists non-U.S. government research support; sponsor and conflicts unavailable.
Study source ↓
Collagen peptides versus omega-3 plus vitamin E in canine osteoarthritis

Placebo-controlled, double-blind interventional study with an omega-3 plus vitamin E comparator group · ingredient

Only the collagen group showed significant gains on treadmill force-plate measures and owner pain scores; the omega-3 plus vitamin E group did not.

Limitations: Omega-3 was a comparator, not the tested product; 31 dogs total; vitamin E combined with omega-3.

Species
dog
Participants / condition
31 dogs with naturally occurring osteoarthritis
Formulation
Omega-3 fatty acids plus vitamin E comparator product, versus collagen peptides
Studied amount, not dosing advice
Omega-3 amount not reported in the available text
Duration
12 weeks
Funding / conflicts
Funded by GELITA AG, which paid financial compensation to three authors; the funding statement says GELITA had no additional role in design, data collection, analysis, decision to publish or manuscript preparation. One author is employed by GELITA AG, and another is a co-inventor of patents concerning collagen peptides.
Study source ↓
Systematic review of nutraceuticals for osteoarthritis signs

Systematic review of controlled trials in horses, dogs and cats (16 of 22 papers in dogs) · ingredient

Evidence was low for all nutraceuticals except omega-3 in dogs, which the authors rated as the exception.

Limitations: 2012 review; limited numbers of rigorous trials and participants; abstract only.

Species
dog
Participants / condition
Dogs within a mixed-species review; dog subset only: omega-3 supplemented diets
Formulation
Omega-3 supplemented diets; product details not reported in abstract
Studied amount, not dosing advice
Not reported in abstract
Duration
Not reported in abstract
Funding / conflicts
Not reported in abstract; unavailable.
Study source ↓
"Omega-3s support immune system, heart, kidney, brain, and vision health" No evidence found

No applicable dog studies on immune, heart, kidney, brain or vision outcomes with fish-oil omega-3s were retrieved in this search. Retrieved dog papers on cognitive dysfunction and a diet-induced metabolic model did not test omega-3s for these outcomes. This is absence from the search, not a finding of no benefit.

Source: Welactin Canine Omega-3 Supplement: manufacturer product page →

"Recommended for dogs of all sizes and life stages" No evidence found

Reviewed dog trials enrolled dogs with osteoarthritis or skin disease; none reported on puppies, seniors, or small and large breeds as groups. No safety data across life stages were found in the retrieved sources. The label's serving chart starts at 5 lb dogs.

Source: Welactin Canine Omega-3 Supplement: manufacturer product page →

Signals

  • The 'backed by science' line is not tied to any Welactin trial, and none was found in this search (label).
  • The 'more than 80 quality checks' and 'thorough quality inspections' statements name no third-party test or seal on the reviewed page (label).
  • The 'number one veterinarian recommended' lines rest on a survey of vets who recommended supplements; the page text gives no sample size or method, and a recommendation survey is not clinical evidence (label).
  • Nutramax Laboratories did not appear in the NASC member list checked 2026-11-03, so no NASC seal was confirmed (nasc).
  • Per-scoop amounts are printed: 1,610 mg total omega-3 and 1,330 mg EPA+DHA per 6 mL scoop (label).
  • A weight-based serving chart is printed on the product page (label).

Dose vs studies

Label amounts at the label's daily directions, per kg of body weight, compared with what dogs studies used. This compares the label with research. It is not dosing advice.

Total omega-3 fatty acids Not comparable

Label: 1610 mg per scoop · about 62.3-177.5 mg/kg/day

Studied: 69 mg/kg/day EPA+DHA

The label states Total omega-3 fatty acids; studies measured EPA+DHA.

Fish oil Depends on dog size

Label: 1330 mg per scoop · about 51.4-146.6 mg/kg/day

Studied: 69 mg/kg/day EPA+DHA

Evidence checks

Species and formulation relevance

All study rows are dog trials, so species fits, but not all tested fish oil: one skin trial had a flax oil arm and one joint trial tested collagen against an omega-3 plus vitamin E comparator. None tested Welactin; no exact-product trial was found in this search. Joint trials mostly used fish-oil foods, and only one joint oil trial gave an EPA+DHA amount (69 mg/kg/day). Skin trials were in itchy or atopic dogs. [pmid27269707, pmid34645070, pmid15206474, pmid39298537]

Dose comparison with research

The label lists 1,330 mg EPA+DHA per scoop. Across the printed weight chart that works out to about 51 to 147 mg/kg per day, which sits below and above the 69 mg/kg/day in the joint oil trial depending on dog weight. The 1,610 mg total omega-3 figure is not directly comparable because studies measured EPA+DHA. This compares label to research, not advice. [label, pmid27269707]

Label transparency

The page prints per-scoop total omega-3 and EPA+DHA amounts and a weight-based serving chart. Its guaranteed analysis does not break out EPA and DHA separately, and label images were not independently verified. [label]

Independent quality testing

The product page cites quality inspections and 80+ quality checks but names no third-party test or seal. Nutramax Laboratories did not appear on the NASC member list when checked 2026-11-03. That is a company-level snapshot, not a test of this product, and no independent test of Welactin was found in the reviewed material. [label, nasc]

Sources (11)

  1. 1. Welactin Canine Omega-3 Supplement: manufacturer product page →

    Manufacturer · Accessed 2026-11-05

  2. 2. NASC member list, checked 2026-11-03 →

    Quality standard · Accessed 2026-11-03

  3. 3. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. →

    Study · Accessed 2026-11-05

  4. 4. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. →

    Study · Accessed 2026-11-05

  5. 5. A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. →

    Study · Accessed 2026-11-05

  6. 6. Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis. →

    Research review · Accessed 2026-11-05

  7. 7. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. →

    Study · Accessed 2026-11-05

  8. 8. The oral intake of specific Bioactive Collagen Peptides (BCP) improves gait and quality of life in canine osteoarthritis patients-A translational large animal model for a nutritional therapy option. →

    Study · Accessed 2026-11-05

  9. 9. Effect of omega-3 fatty acids on canine atopic dermatitis. →

    Study · Accessed 2026-11-05

  10. 10. Double-blinded Crossover Study with Marine Oil Supplementation Containing High-dose icosapentaenoic Acid for the Treatment of Canine Pruritic Skin Disease. →

    Study · Accessed 2026-11-05

  11. 11. A placebo-controlled, double-blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs. →

    Study · Accessed 2026-11-05

How this report was produced

AI-assisted evidence analysis. We reviewed published material, not physical products.

Automated source and evidence checks completed on 2026-11-05. These checks are not veterinary review.

Research scope and outstanding checks

Four literature queries ran: two for systematic reviews of nutraceuticals in canine osteoarthritis and two for Welactin Canine. Ingredient records for EPA+DHA covering osteoarthritis and skin/coat were also used. The product page and an NASC list check (2026-11-03) were reviewed. Most studies were read as abstracts only, so methods, effect sizes and funding are often unavailable. The search was not exhaustive. Excluded: unrelated dog papers (canine cognitive dysfunction survey, diet-induced metabolic syndrome model, a necrolytic dermatitis case report), combination-product and diet trials that cannot isolate fish oil, and any human, rodent or cat data. The mixed dog-and-cat 2022 meta-analysis and COAST guideline were not used as dog study rows because their dog-specific omega-3 results were not identifiable in the available text.

Focused research searches:

  • (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • (Welactin AND Canine) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (Welactin AND Canine) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • Any trial of Welactin Canine itself
  • Dog evidence for immune, heart, kidney, brain and vision outcomes
  • Safety and benefit data across puppies, seniors and different sizes
  • Full methods, effect sizes and funding for most cited trials (abstracts only)
  • A named third-party test or seal for this product
  • Method and sample size of the veterinarian recommendation surveys

More dog supplements reviews

Check another product
Paste a product page to request an automated evidence review.